Ergin Aydemir
Dr. Abdurrahman Yurtaslan Ankara Oncology Research And Training Hospital
Ankara, Turkey
Ankara, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
From the stands to survival fandom, a psychosocial force in the fight against cancer.
Journal: Journal of health psychology
Published: June 23, 2026
Neutropenia and G-CSF use in patients receiving FOLFOX during the COVID-19 pandemic.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: March 26, 2026
A novel inflammation and tumor marker-based prognostic score, neutrophil-lymphocyte ratio-C-reactive protein-Ca19-9, in metastatic gastric cancer.
Journal: Oncology letters
Published: January 15, 2026
Large Language Models as Decision-support Tools for Adjuvant Therapy Planning in Early-stage Hormone Receptor-positive Breast Cancer.
Journal: Cancer diagnosis & prognosis
Published: January 12, 2026
NOTCH1: A Potential New Biomarker in the Era of Immunotherapy?
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 11, 2025
Unilateral facial nerve paralysis following prolonged weekly paclitaxel therapy: a rare case of cranial neurotoxicity with diagnostic challenges.
Journal: Journal of chemotherapy (Florence, Italy)
Published: July 28, 2025
Reevaluating the prognostic impact of spread through air spaces and lymphovascular invasion in resected non-small cell lung cancer: the role of systemic therapy in survival outcomes.
Journal: Updates in surgery
Published: April 25, 2025
The Role of Artificial Intelligence (ChatGPT-4o) in Supporting Tumor Board Decisions.
Journal: Journal of clinical medicine
Published: April 18, 2025
Prognostic impact of preoperative cachexia in patients undergoing major hepatopancreatobiliary surgery for malignancy.
Journal: Clinical nutrition (Edinburgh, Scotland)
Published: April 18, 2025
Timing of Dose Reductions and Survival Outcomes in Metastatic Breast Cancer Patients Treated with Cyclin-Dependent Kinase 4/6 Inhibitors.
Journal: Current oncology (Toronto, Ont.)
Published: October 16, 2024
Monitoring the Response of Cyclin-Dependent Kinase 4/6 Inhibitors with Mean Corpuscular Volume.
Journal: Current oncology (Toronto, Ont.)
Published: July 29, 2024
Last Updated: 09/26/2026